Please wait



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)


SCHEDULE 13D/A 0001402371 XXXXXXXX LIVE 1 Common Stock, $0.0001 par value per share 03/27/2025 false 0001690080 68236V302 180 LIFE SCIENCES CORP. 3000 El Camino Real Suite D131 Palo Alto CA 94306 Anthony Brian Goodman 310-929-7252 3651 Lindell Road, Suite D131, Las Vegas NV 89103 Y Anthony Brian Goodman OO N C3 0.00 4318000.00 0.00 4318000.00 4318000.00 N 52.8 IN (8),(10),(11),(13) Includes 3,000,000 shares of common stock issuable upon exercise of the Warrants (discussed in greater detail in Item 3 of the Original 13D). (13) Based on 5,185,780 shares of Common Stock of the Company (as defined below) outstanding as of March 31, 2025, as set forth on the cover page of the Issuer's Annual Report on Form 10-K for the year ended December 31, 2024, and assuming the exercise of all outstanding Warrants for cash. 0001402371 N Elray Resources, Inc. OO N NV 0.00 4318000.00 0.00 4318000.00 4318000.00 N 52.8 CO (8),(10),(11),(13) Includes 3,000,000 shares of Common Stock issuable upon exercise of the Warrants (discussed in greater detail in Item 3 of the Original 13D). (13) Based on 5,185,780 shares of Common Stock of the Company (as defined below) outstanding as of March 31, 2025, as set forth on the cover page of the Issuer's Annual Report on Form 10-K for the year ended December 31, 2024, and assuming the exercise of all outstanding Warrants for cash. Common Stock, $0.0001 par value per share 180 LIFE SCIENCES CORP. 3000 El Camino Real Suite D131 Palo Alto CA 94306 This Amendment No. 1 (the "Amendment") amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the "Commission") on January 10, 2025 (the "Original 13D"), by Anthony Brian Goodman and Elray Resources, Inc. ("Elray") (the Schedule 13D as amended to date, the "Schedule 13D"). As used in this Amendment: "Common Stock" means the common stock of the Issuer; "Issuer" or "Company" means 180 Life Sciences Corp.; and "Reporting Persons" means Anthony Brian Goodman and Elray. Other capitalized terms used but not otherwise defined in this Amendment have the meanings ascribed to such terms in the Schedule 13D. Except as expressly amended and supplemented by this Amendment, the Schedule 13D is not amended or supplemented in any respect, and the disclosures set forth in the Schedule 13D, other than as amended herein are incorporated by reference herein. Item 3 is hereby amended and supplemented by adding the following at the end thereof: On March 27, 2025, Elray converted all 1,000,000 outstanding shares of Series B Convertible Preferred Stock of the Company which it then held into 1,318,000 shares of Common Stock of the Issuer (1.318 shares of Common Stock for each share of Series B Convertible Preferred Stock converted), in accordance with the terms of such preferred stock and the optional conversion right set forth therein. The aggregate number of shares of Common Stock beneficially owned by each Reporting Person and, for each Reporting Person, the number of shares as to which there is sole power to vote or to direct the voting thereof, shared power to vote or to direct the voting thereof, sole power to dispose or to direct the disposition thereof, or shared power to dispose or to direct the disposition thereof, are set forth on rows 7 through 11 and row 13 of the cover pages of this Schedule 13D and are incorporated herein by this reference thereto. The following table summarizes the number of shares beneficially owned by each Reporting Person, as to which they have (1) sole power to vote or to direct the vote, (2) shared power to vote or to direct the vote sole power to dispose, (3) sole power to dispose or to direct the disposition, and (4) shared power to dispose or to direct the disposition: Reporting Person Sole Power to Vote or to Direct the Vote Shared Power to Vote or to Direct the Vote Sole Power to Dispose or to Direct the Disposition Shared Power to Dispose or to Direct the Disposition Anthony Brian Goodman -- 4,318,000 (1) Elray Resources, Inc. -- 4,318,000 (1) (1) Includes 3,000,000 shares of Common Stock issuable upon exercise of the Warrants. None of the Reporting Persons have effected any transactions in the Common Stock during the past 60 days, except as discussed in Item 3, above. To the knowledge of the Reporting Persons, only the Reporting Persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock of the Issuer reported by this Schedule 13D. N/A. Anthony Brian Goodman /s/ Anthony Brian Goodman Anthony Brian Goodman 04/11/2025 Elray Resources, Inc. /s/ Anthony Brian Goodman Anthony Brian Goodman, Chief Executive Officer 04/11/2025